Screener
MBX Biosciences, Inc. MBX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210593
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 27,265 | 26,529 |
| Loss from operations | (27,265) | (26,529) |
| Interest and other income, net | 3,748 | 2,649 |
| Net loss | $(23,517) | $(23,880) |
| Unrealized loss on marketable securities | (892) | (2) |
| Total other comprehensive loss | (892) | (2) |
| Total comprehensive loss | $(24,409) | $(23,882) |
| Net loss attributable to common stockholders | $(23,517) | $(23,880) |
Item 1. Financial Statements.
FAQ
- What is MBX Biosciences, Inc.'s net income?
- MBX Biosciences, Inc. (MBX) reported net income of -$23.52M in Q1 2026.
- How has MBX Biosciences, Inc.'s net income changed year-over-year?
- MBX Biosciences, Inc.'s net income increased by 1.5% year-over-year, from -$23.88M to -$23.52M.
- What is the long-term trend for MBX Biosciences, Inc.'s net income?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s net income has grown at a 63.5% compound annual growth rate (CAGR), from -$32.56M to -$87M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about MBX Biosciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude